<2> Form 13G Inspira Technologies OXY B.H.N. Ltd: A Comprehensive Analysis
<3> Introduction
<4> Inspira Technologies OXY B.H.N. Ltd, a leading provider of innovative medical solutions, has recently filed a Form 13G with the U.S. Securities and Exchange Commission (SEC). This filing provides valuable insights into the company’s ownership structure and potential implications for investors. In this article, we will delve into the details of the Form 13G and analyze its significance in the context of current industry standards.
<3> Background
<5> Inspira Technologies OXY B.H.N. Ltd is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol OXY. The company specializes in developing and commercializing innovative medical solutions, including oxygen concentrators and other respiratory care products.
<4> Form 13G Filing
<6> On February 28, 2024, Inspira Technologies OXY B.H.N. Ltd filed a Form 13G with the SEC, disclosing that a new 5% or greater shareholder has emerged. The filing reveals that the new shareholder, identified as “Investor A,” has acquired a significant stake in the company, consisting of approximately